Insulin Detemir (Vials) and Ranibizumab
Determining the interaction of Insulin Detemir (Vials) and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Detemir (Vials)-Ranibizumab Intraocular
- Insulin Detemir (Vials)-Ranibizumab ophthalmic
- Insulin Detemir (Vials)-Ranitidine
- Insulin Detemir (Vials)-Ranitidine Capsule
- Insulin Detemir (Vials)-Ranitidine Hydrochloride
- Insulin Detemir (Vials)-Ranitidine Injection
- Ranibizumab-Insulin detemir Subcutaneous
- Ranibizumab-Insulin glargine
- Ranibizumab-Insulin Glargine (U-100) Cartridge Systems and Pens
- Ranibizumab-Insulin Glargine (U-100) Vials
- Ranibizumab-Insulin Glargine (U-300) Pens
- Ranibizumab-Insulin glargine and lixisenatide